Trademark: 79156265
Status Date
Wednesday, November 16, 2022
Registration Number
4948428
Registration Date
Tuesday, May 3, 2016
Filing Date
Friday, August 29, 2014
Published for Opposition
Tuesday, February 16, 2016
5 Biological preparations for pharmaceutical use to stimulate hair pigmentation and reverse the gray process, to induce skin pigmentation, to strengthen skin's defenses against harmful effects of UV, to reduce skin erythema, to protect and repair DNA damage caused by UV exposure, to reduce inflammatory response; biological preparations for medical use to stimulate hair pigmentation and reverse the gray process, to induce skin pigmentation, to strengthen skin's defenses against harmful effects of UV, to reduce skin erythema, to protect and repair DNA damage caused by UV exposure, to reduce inflammatory response; pharmaceutical products for use in dermatology; chemical preparations for pharmaceutical or medical purposes, namely, stimulating hair pigmentation and reversing the gray process, inducing skin pigmentation, strengthening skin's defenses against harmful effects of UV, reducing skin erythema, protecting and repairing DNA damage caused by UV exposure, reducing inflammatory response; pharmaceutical products to stimulate hair pigmentation and reverse the gray process, to induce skin pigmentation, to strengthen skin's defenses against harmful effects of UV, to reduce skin erythema, to protect and repair DNA damage caused by UV exposure, to reduce inflammatory response
3 Cosmetic products, namely, skin creams, hair care products, namely, shampoos, hair creams, non-medicated hair serums, non-medicated balms for use on hair cosmetic creams; cosmetic products for skin care, namely, skin creams, beauty cream and beauty serums, beauty balm creams; cosmetic products for skin tanning, namely, skin creams, non-medicated skin serums, lip balms
1 Chemical products for hair care, anti-aging hair care, skin care and sun care for the cosmetic industry, biological products for the pharmaceutical industry, namely, biomimetic component, namely, biomimetic peptide, organic molecule agonist of MSH, to stimulate hair pigmentation and reverse the gray process, to induce skin pigmentation, to strengthen skin's defenses against harmful effects of UV, to reduce skin erythema, to protect and repair DNA damage caused by UV exposure, to reduce inflammatory response
Nov 16, 2022
Notice Of Acceptance Of Sec. 71 - E-Mailed
Nov 16, 2022
Registered-Sec.71 Accepted
Nov 7, 2022
Case Assigned To Post Registration Paralegal
May 20, 2022
Teas Section 71 Received
Feb 17, 2017
Final Decision Transaction Processed By Ib
Aug 8, 2016
Generic Madrid Transaction Sent To Ib
Aug 8, 2016
Generic Madrid Transaction Created
Aug 3, 2016
Final Disposition Notice Created, To Be Sent To Ib
Jul 21, 2016
New Representative At Ib Received
May 3, 2016
Registered-Principal Register
Feb 16, 2016
Published For Opposition
Feb 13, 2016
Notification Processed By Ib
Jan 27, 2016
Notification Of Possible Opposition Sent To Ib
Jan 27, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 27, 2016
Notice Of Publication
Jan 14, 2016
Law Office Publication Review Completed
Dec 29, 2015
Approved For Pub - Principal Register
Dec 22, 2015
Teas/Email Correspondence Entered
Dec 22, 2015
Correspondence Received In Law Office
Dec 22, 2015
Teas Request For Reconsideration Received
Jul 31, 2015
Final Refusal Mailed
Jul 30, 2015
Final Refusal Written
Jun 24, 2015
Teas/Email Correspondence Entered
Jun 24, 2015
Correspondence Received In Law Office
Jun 17, 2015
Assigned To Lie
Jun 10, 2015
Teas Response To Office Action Received
Jan 4, 2015
Refusal Processed By Ib
Dec 16, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Dec 16, 2014
Refusal Processed By Mpu
Dec 14, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Dec 13, 2014
Non-Final Action Written
Dec 13, 2014
Application Filing Receipt Mailed
Dec 12, 2014
Assigned To Examiner
Dec 9, 2014
New Application Office Supplied Data Entered
Dec 4, 2014
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
